drugset / Trial / NCT02623491
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55375515 in Healthy Participants
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of JNJ-55375515 in healthy participants after administration of single and multiple oral doses.
Timeline
- Start
- 2015-11
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-55375515 | Unknown | 0.75 mg | Oral |
| Subject | JNJ-55375515 | Unknown | 100 mg | Oral |
| Subject | JNJ-55375515 | Unknown | 200 mg | Oral |
Indications
No indication recorded.